top of page
AXIOM CROSSROADS SUMMIT
The biopharma ecosystem stands at a crossroads. With anemic R&D delivery, failed clinical trials, access challenges, declining valuations, escalating clinical trial costs, patient identification, the hurdles we face are significant. Listen to leading experts from academia, biopharma, and the investment community discuss strategies to navigate these in oncology and rare diseases.
SUMMIT FACULTY
Paul
Biondi
Michelle
Werner
Giovanni
Abbadessa
Irina
Margine
Fatma
Ocak
Biren
Amin
Uciane
Scarlett
Robert
LaCaze
Shruti
Agrawal
Lea
Hachigian
Christiana
Bardon
Alan
Bash
Lisa
Mahnke
Gaurav
Kandhari
Corey
Langer
Hossein
Borghaei
SUMMIT SESSIONS
Axiom Crossroads Summit
All Categories
"Thanks to team Axiom for hosting and to all the speakers and panelists for sharing their knowledge, insights and wisdom!!!"
SEE YOU AT THE
AXIOM CROSSROADS SUMMIT
2025
bottom of page